Cefotaxime
Cefotaxime is a third-generation cephalosporin antibiotic used to treat serious bacterial infections, including pneumonia, meningitis, septicaemia, urinary tract infections, bone and joint infections, and infections of the abdomen or reproductive organs caused by susceptible bacteria. It works by inhibiting bacterial cell-wall synthesis, leading to bacterial death, and has activity against a broad range of Gram-positive and Gram-negative organisms. Cefotaxime is supplied as a powder for injection and administered intravenously or intramuscularly under medical supervision. Common side effects include injection-site pain, diarrhoea, nausea, skin rash and elevated liver enzymes. Serious risks include severe allergic reactions, antibiotic-associated colitis and neurological effects, particularly with high doses or impaired kidney function. Dose adjustment and appropriate monitoring may be necessary in patients with renal impairment.
Cefotaxime was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Cefotaxime, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Cefotaxime from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Cefotaxime, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
